source · text/markdown
source_a2e06252642543a6
sha256 cd39502c372f73bcf7adefb84777c56a5b082e77b779a4a6ad92993532316cee
by researka:v2 · 2026-06-29 02:33:33.459577+04:00
# Alpha memo: resveratrol exercise animal-disease cardiac/aortic-to-aged-men skeletal/metabolic boundary **Research question:** How far does the Receipt 1 signal transfer across the setting tested by Receipt 2? **One-sentence alpha:** Receipt 1 supports a combined-protocol cardiac/aortic signal in animal-disease; Receipt 2 separates the components and limits transfer to skeletal/metabolic in aged-men. **Receipt 1:** Beneficial effects of resveratrol and exercise training on cardiac and aortic function and structure in the 3xTg mouse model of Alzheimer’s disease | 2019 | 10.2147/dddt.s196119 **Receipt 2:** Exercise training, but not resveratrol, improves metabolic and inflammatory status in skeletal muscle of aged men | 2014 | 10.1113/jphysiol.2013.270256 **Synthesis:** Receipt 1 reports Beneficial effects of resveratrol and exercise training on cardiac and aortic function and structure in the 3xTg mouse model of Alzheimer’s disease; excerpt: Background: Studies have indicated an association between Alzheimer’s disease (AD) and increased risk of developing cardiovascular complications. in an animal model. Receipt 2 reports Exercise training, but not resveratrol, improves metabolic and inflammatory status in skeletal muscle of aged men; excerpt: Exercise training increased skeletal muscle peroxisome proliferator-activated receptor-γ co-activator-1α mRNA ~1.5-fold, cytochrome c protein ~1.3-fold, cytochrome c oxidase I protein ~1.5-fold, citrate synthase activity ~1.3-fold, 3-hydrox in a human study. The comparison is bounded to resveratrol / exercise / training, and should not be read as advice, settled science, or a broad class claim. **Bounded contrast:** Receipt 1 axes: mice, mouse, disease, alzheimer, exercise, training, aortic, cardiac. Receipt 2 axes: men, aged, human, healthy, endurance, exercise, training, skeletal. **Interpretation:** Receipt 1 establishes cardiac/aortic in animal-disease; Receipt 2 establishes skeletal/metabolic in aged-men; the update is the boundary between those receipt-owned axes, not a universal benefit or failure claim. **Why this is surprising:** The surprise is not generic translation failure; it is the receipt-owned boundary between Receipt 1's intervention/model setting and Receipt 2's population and endpoints for resveratrol / exercise / training. **Limitations:** This pair does not isolate which axis drives the split: disease model/population health, species/population, modality, endpoint class, dose, duration, single-component attribution if a receipt tests a combined protocol. **Falsifier:** A matched aged-men study where skeletal/metabolic endpoints improve under the same isolated intervention would overturn the update. **Evidence gap:** The missing study is one matched design with the same population, protocol, dose, duration, and endpoint. **Next test:** Run the same resveratrol / exercise / training comparison in one matched design before treating the signal as general.
metadata
{
"article_type": "alpha_memo",
"domain_slug": "longevity_research",
"researka_object_type": "submission",
"researka_submission_id": "dd36fedd-dde5-4906-94ca-df063836749e",
"title": "Alpha memo: resveratrol exercise animal-disease cardiac/aortic-to-aged-men skeletal/metabolic boundary"
}